CBSA is thrilled to announce our 2024 Regulatory Symposium!
With the speed of innovation accelerating the regulatory framework is working to catch up, the world over. The European Union has passed a myriad of new legislation, which is coming into force and will dramatically affect the use of AI and the development of digital health tools, both abroad and in the United States. Changes in large markets have a global impact in the way businesses operate. Understanding these impacts is imperative to the success of life sciences businesses, whether they are using AI to develop medical devices, drugs and biologics, or the AI is the product.
Join us virtually on Wednesday, May 15, for an in depth look at the United States and Europe’s Data, AI, and Cyber Strategies with industry experts from Hogan Lovells and the CSA Group, in addition to insights from global life sciences companies who are preparing for the changes.
- Arne Thiermann, LL.M. (LSE) | Partner, Global Regulatory, Hogan Lovells
- Fabien Roy | Partner, Global Regulatory, Hogan Lovells
- Jodi Scott | Partner, Global Regulatory, Hogan Lovells
- Shane O'Neill | New Business Account Manager, CSA Group
Register today: https://lnkd.in/dsUssSjZ
#CoBioScience #StrongerTogether #InnovationForward #BuildingMomentum #ForgingLifeSciencesFrontier